Investment
Features
FeesSafety
Academy
More
Pluang+

Compare International Business Machines Corp (IBM) vs Revvity Inc (RVTY) Price & Performance

International Business Machines CorpTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

International Business Machines Corp vs Revvity Inc — how do they compare? International Business Machines Corp trades at $235.68 (market cap $224.62B), while Revvity Inc trades at $117.6 (market cap $12.91B). The key difference: International Business Machines Corp is far larger — about 17.4× Revvity Inc's market cap, and International Business Machines Corp pays the higher dividend (2.84%). Which is the better fit depends on your goals.

IBMRVTY
Market Cap
$224.62B$12.91B
Volume
4,481,527
Sector
TechnologyTechnology
52-Week High
$329.23$117.75
52-Week Low
$205.77$82.26
Enterprise Value
$281.76B$15.23B
Dividend Yield
2.84%0.24%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

International Business Machines Corp

IBM trades at $234.91, down 0.59% today, with a mixed technical outlook showing bearish moving averages but bullish overall signals. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results pending. The company secured a $240 million AI deal with Together AI, boosting sentiment, but faces a securities fraud investigation following a 25% stock drop. Fundamentals are solid with revenue growth to $67.54 billion in 2025 and a net income margin of 15.52%, though cash flow turned negative.

Outlook is cautiously optimistic with a consensus price target of $257.38, implying 9.6% upside, supported by AI and cloud growth. Risks include the ongoing fraud probe, competitive pressures, and high debt levels. Investors should weigh strong profitability against legal and execution uncertainties in a volatile market.

Revvity Inc

RVTY trades at $116.10, up 0.07% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $1.41, surpassing the $1.21 estimate, and raised its full-year outlook due to robust diagnostics demand. Revenue remains steady around $2.9 billion, with a net income margin of 8.16%. Analyst consensus is a Buy with a $120.50 price target, and recent news highlights product launches like the SuperFlex prenatal system and high-throughput TB testing platform.

The outlook for RVTY is positive, supported by earnings momentum and strategic innovations, but investors face risks from high valuation multiples and competitive pressures in the healthcare sector. The stock's proximity to its consensus target suggests limited near-term upside, requiring careful monitoring of execution against raised guidance.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About International Business Machines Corp

International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.

Read more on IBM

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY